Adverse events associated with neonatal exchange transfusion for hyperbilirubinemia Authors
First Online: 18 April 2009 Received: 10 September 2007 Accepted: 10 January 2008 DOI:
Cite this article as: Behjati, S., Sagheb, S., Aryasepehr, S. et al. Indian J Pediatr (2009) 76: 83. doi:10.1007/s12098-009-0033-1 Abstract
To estimate the incidence of blood exchange and determine causes and complication of blood exchange and identify strategies for risk reduction of Kernicterus in newborn with jaundice. From march 2004 to march 2006 in neonatal Department in children hospital, medical center Tehran, Iran,346 neonates were admitted as neinatal jaundice without sign and symptoms of infections. We identified causes and complications of exchange. Of 346 infants with jaundice who received phototherapy. 50, 14.45 percent cases underwent exchange transfusion with mean age 9.38+5.75 days. The mean total Serum billirubin level was 29.39+6.13mg/dl. ABO incompatibility was the most common cause for hyperbillirubinemia.the incidence of apnea was 12% there was no direct death from exchange transfusion. To make payment women aware to cbserve jaundice regularly after birth of their child and short breast feeding to control dehydretion.
Key words Adverse events Neonatal exchange transfusion Hyperbilirubinemia Abbreviations SPSS
Statistical package for the social sciences
Red blood cell
Complete blood count
Peripheral blood smear
Glucose 6 phosphate dehydrogenase deficiency
Alexandra Brito M, Silva RF, Brites D. Bilirubin toxicity to human erythrocytes: a review.
Clin Chim Acta
2006; 374: 46–56.
Maisels MJ, Kring E. The contribution of hemolysis to early jaundice in normal newborns.
2006; 118: 276–279.
Barbara J Stoll. Jaundice and Hyperbilirubinemia in the Newborn-Kernicterus. In Richard E. Behram, Robert M. Kleigman, Hal B. Jenson, eds. Nelson Textbook of Pediatrics, 17
th ed. Saunders, 2004; 592–599.
Sgro M, Campbell D, Shah V. Incidence and causes of severe neonatal hyperbilirubinemia in Canada.
200612; 175: 587–590.
Haung MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates.
2004; 56: 682–689.
Gourley GR. Another risk factor for neonatal hyperbilirubinemia.
J Pediatr Gastroenterol Nutr
2005; 40: 388–389.
Chen WX, Wong VC, Wong KY. Neurodevelopmental outcome of severe neonatal hemolytic hyperbilirubinemia.
J Child Neurol
2006; 21: 474–479.
Lo YS, Lu CC, Chen LY, Tsai LT. Clinical studies of neonatal hyperbilirubinemia treated with blood exchange transfusion.
Gaoxiong Yi Xue Ke Xue Za Zhi
1990; 6: 556–564.
Weisz B, Belson A, Milbauer B, Reif S. Complications of exchange transfusion in term and preterm newborns.
1996; 130: 170–223
Tan KL, Phua KB, Ang PL. The mortality of exchange transfusions.
Med J A ust 1976; 1: 473–476.
Tioseco JA, Aly H, Milner J, Patel K, EI-Mohandes AA. Does gender affect neonatal hyperbilirubinemia in low-birthweight infants?
Pediatr Crit Care Med
2005; 6: 171–174.
Kaplan M, Hammerman C. Glucose -6-phosphate dehydrogenase deficiency: a hidden risk for kernicterus.
2004; 28: 356–364.
Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s.
2004; 144: 626–631.
Ogunfowora OB, Adefuye PO, Fetuga MB. What do expectant mothers know about neonatal jaundice?
International Electronic Journal of Health Education 2006; 9:134–140. Copyright information
© Dr. K C Chaudhuri Foundation 2009